Cargando…
Daratumumab, an original approach for treating multi-refractory autoimmune cytopenia
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634173/ https://www.ncbi.nlm.nih.gov/pubmed/34348453 http://dx.doi.org/10.3324/haematol.2021.279232 |
| _version_ | 1784608083145654272 |
|---|---|
| author | Crickx, Etienne Audia, Sylvain Robbins, Ailsa Boutboul, David Comont, Thibault Cheminant, Morgane Oksenhendler, Eric Godeau, Bertrand Michel, Marc Mahevas, Matthieu |
| author_facet | Crickx, Etienne Audia, Sylvain Robbins, Ailsa Boutboul, David Comont, Thibault Cheminant, Morgane Oksenhendler, Eric Godeau, Bertrand Michel, Marc Mahevas, Matthieu |
| author_sort | Crickx, Etienne |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8634173 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86341732021-12-17 Daratumumab, an original approach for treating multi-refractory autoimmune cytopenia Crickx, Etienne Audia, Sylvain Robbins, Ailsa Boutboul, David Comont, Thibault Cheminant, Morgane Oksenhendler, Eric Godeau, Bertrand Michel, Marc Mahevas, Matthieu Haematologica Letters to the Editor Fondazione Ferrata Storti 2021-08-05 /pmc/articles/PMC8634173/ /pubmed/34348453 http://dx.doi.org/10.3324/haematol.2021.279232 Text en Copyright© 2021 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Letters to the Editor Crickx, Etienne Audia, Sylvain Robbins, Ailsa Boutboul, David Comont, Thibault Cheminant, Morgane Oksenhendler, Eric Godeau, Bertrand Michel, Marc Mahevas, Matthieu Daratumumab, an original approach for treating multi-refractory autoimmune cytopenia |
| title | Daratumumab, an original approach for treating multi-refractory autoimmune cytopenia |
| title_full | Daratumumab, an original approach for treating multi-refractory autoimmune cytopenia |
| title_fullStr | Daratumumab, an original approach for treating multi-refractory autoimmune cytopenia |
| title_full_unstemmed | Daratumumab, an original approach for treating multi-refractory autoimmune cytopenia |
| title_short | Daratumumab, an original approach for treating multi-refractory autoimmune cytopenia |
| title_sort | daratumumab, an original approach for treating multi-refractory autoimmune cytopenia |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634173/ https://www.ncbi.nlm.nih.gov/pubmed/34348453 http://dx.doi.org/10.3324/haematol.2021.279232 |
| work_keys_str_mv | AT crickxetienne daratumumabanoriginalapproachfortreatingmultirefractoryautoimmunecytopenia AT audiasylvain daratumumabanoriginalapproachfortreatingmultirefractoryautoimmunecytopenia AT robbinsailsa daratumumabanoriginalapproachfortreatingmultirefractoryautoimmunecytopenia AT boutbouldavid daratumumabanoriginalapproachfortreatingmultirefractoryautoimmunecytopenia AT comontthibault daratumumabanoriginalapproachfortreatingmultirefractoryautoimmunecytopenia AT cheminantmorgane daratumumabanoriginalapproachfortreatingmultirefractoryautoimmunecytopenia AT oksenhendlereric daratumumabanoriginalapproachfortreatingmultirefractoryautoimmunecytopenia AT godeaubertrand daratumumabanoriginalapproachfortreatingmultirefractoryautoimmunecytopenia AT michelmarc daratumumabanoriginalapproachfortreatingmultirefractoryautoimmunecytopenia AT mahevasmatthieu daratumumabanoriginalapproachfortreatingmultirefractoryautoimmunecytopenia |